Table 2.
Correlations between lncRNA, E-cadherin, N-cadherin and clinical features
| CCAT1 | E-cadherin | N-cadherin | ||||
|---|---|---|---|---|---|---|
|
|
||||||
| Correlation | P | Correlation | P | Correlation | P | |
| Gender | 0.228 | 0.262 | 0.422 | 0.307 | 0.375 | 0.517 |
| Age | 0.561 | 0.674 | 0.664 | 0.521 | 0.486 | 0.388 |
| Tumor size | 0.279 | 0.098 | 0.571 | 0.129 | 0.334 | 0.248 |
| Differentiation | 0.607 | 0.188 | 0.774 | 0.286 | 0.687 | 0.122 |
| Local invasion | 0.445 | 0.005 | 0.432 | 0.011 | 0.226 | 0.003 |
| Dukes staging | 0.318 | 0.023 | 0.524 | 0.001 | 0.537 | 0.038 |
| Vascular invasion | 0.087 | 0.002 | 0.408 | 0.001 | 0.069 | 0.001 |
| Tumor location | 0.117 | 0.359 | 0.219 | 0.406 | 0.367 | 0.348 |
| CEA (ng/ml) | 0.042 | 0.116 | 0.174 | 0.552 | 0.471 | 0.295 |
| CA19-9 (U/ml) | 0.561 | 0.008 | 0.198 | 0.001 | 0.582 | 0.001 |